Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 3 de 3
Filtre
1.
Braz. j. infect. dis ; 17(4): 431-437, July-Aug. 2013. ilus, tab
Article Dans Anglais | LILACS | ID: lil-683130

Résumé

OBJECTIVES: To study the potential factors include gene mutation, efflux pump and alteration of permeability associated with quinolone-resistance of Salmonella enterica strains isolated from patients with acute gastroenteritis and to evaluate the degree of synergistic activity of efflux pump inhibitors when combined with ciprofloxacin against resistant isolates. METHODS: Antimicrobial resistance patterns of fifty-eight Salmonella isolates were tested. Five isolates were selected to study the mechanism of resistance associated with quinolone group, including mutation in topoisomerase-encoding gene, altered cell permeability, and expression of an active efflux system. In addition, the combination between antibiotics and efflux pump inhibitors to overcome the microbial resistance was evaluated. RESULTS: Five Salmonella isolates totally resistant to all quinolones were studied. All isolates showed alterations in outer membrane proteins including disappearance of some or all of these proteins (Omp-A, Omp-C, Omp-D and Omp-F). Minimum inhibitory concentration values of ciprofloxacin were determined in the presence/absence of the efflux pump inhibitors: carbonyl cyanide m-chlorophenylhydrazone, norepinephrin and trimethoprim. Minimum inhibitory concentration values for two of the isolates were 2-4 fold lower with the addition of efflux pump inhibitors. All five Salmonella isolates were amplified for gyrA and parC genes and only two isolates were sequenced. S. Enteritidis 22 had double mutations at codon 83 and 87 in addition to three mutations at parC at codons 67, 76 and 80 whereas S. Typhimurium 57 had three mutations at codons 83, 87 and 119, but no mutations at parC. CONCLUSIONS: Efflux pump inhibitors may inhibit the major AcrAB-TolC in Salmonella efflux systems which are the major efflux pumps responsible for multidrug resistance in Gramnegative clinical isolates.


Sujets)
Humains , Antibactériens/pharmacologie , Fluoroquinolones/pharmacologie , Salmonella enterica/effets des médicaments et des substances chimiques , DNA gyrase/génétique , DNA topoisomerase IV/génétique , Résistance bactérienne aux médicaments/génétique , Tests de sensibilité microbienne , Protéines de transport membranaire/effets des médicaments et des substances chimiques , Salmonella enterica/génétique , Salmonella enterica/isolement et purification
2.
Southeast Asian J Trop Med Public Health ; 2006 Nov; 37(6): 1072-7
Article Dans Anglais | IMSEAR | ID: sea-32164

Résumé

A previous study showed that the 1,10-phenanthroline skeleton was active in vitro against chloroquine-resistant and sensitive strains of Plasmodium falciparum. Based on this skeleton, 8 derivatives of N-alkyl and N-benzyl-1,10-phenanthrolines have been synthesized. This study was conducted to evaluate the in vitro antiplasmodial activity and cytotoxicity of these compounds. The in vitro antiplasmodial activity was tested on two strains of P. falciparum, FCR-3 chloroquine-resistant and D10 chloroquine-sensitive strains, while their cytotoxicity was tested on the Vero cell line. The parasite and cell growth were estimated by hypoxantine-[2,8-3H] uptake after 24- and 72-hour incubation with each compound tested. The control parasite or cell free from any compounds was referred to as having 100% growth. For this radioactive method, the IC50 value showing concentration inhibiting 50% of the parasite growth was determined by probit analysis. The results showed that the highest antiplasmodial activity was observed with (1)-N-benzyl-1,10-phenanthrolinium iodide with the IC50 0.18-0.45 microM, and the IC50 of the compound on Vero cells ranged from 2,582.30 to 7,057.71 microM. The cytotoxic/ antiplasmodial ratio indicates that this compound has high selectivity (10,993 +/- 330.79-38,965 +/- 6,888.27).


Sujets)
Animaux , Survie cellulaire/effets des médicaments et des substances chimiques , Chlorocebus aethiops , Chélateurs/synthèse chimique , Chloroquine/pharmacologie , Anticholinestérasiques/pharmacologie , Résistance aux substances , Indonésie , Paludisme à Plasmodium falciparum/traitement médicamenteux , Protéines de transport membranaire/effets des médicaments et des substances chimiques , Phénanthrolines/synthèse chimique , Plasmodium falciparum/effets des médicaments et des substances chimiques , Protéines de protozoaire/effets des médicaments et des substances chimiques , Cellules Vero/effets des médicaments et des substances chimiques
3.
Genet. mol. res. (Online) ; 4(2): 390-408, 30 jun. 2005. ilus, tab
Article Dans Anglais | LILACS | ID: lil-445280

Résumé

In the struggle for life, the capacity of microorganisms to synthesize and secrete toxic compounds (inhibiting competitors) plays an important role in successful survival of these species. This ability must come together with the capability of being unaffected by these same compounds. Several mechanisms are thought to avoid the toxic effects. One of them is toxin extrusion from the intracellular environment to the outside vicinity, using special transmembrane proteins, referred to as transporters. These proteins are also important for other reasons, since most of them are involved in nutrient uptake and cellular excretion. In cancer cells and in pathogens, and particularly in fungi, some of these proteins have been pointed out as responsible for an important phenotype known as multidrug resistance (MDR). In the present study, we tried to identify in the Paracoccidioides brasiliensis transcriptome, transporter-ortholog genes from the two major classes: ATP binding cassette and major facilitator superfamily transporter. We found 22 groups with good similarity with other fungal ATP binding cassette transporters, and four Paracoccidioides brasilienses assembled expressed sequence tags that probably code for major facilitator superfamily proteins. We also focused on fungicide resistance orthologs already characterized in other pathogenic fungi. We were able to find homologs to C. albicans CDR1, CDR2, and MDR1, Saccharomyces cerevisiae PDR5 and Aspergillus AtrF genes, all of them related to azole resistance. As current treatment for paracoccidioidomycosis mainly uses azole derivatives, the presence of these genes can be postulated to play a similar role in P. brasiliensis, warning us for the possibility of resistant isolate emergence.


Sujets)
Humains , Antifongiques/pharmacologie , Étiquettes de séquences exprimées/métabolisme , Paracoccidioides/effets des médicaments et des substances chimiques , Multirésistance des champignons aux médicaments/génétique , Transcription génétique , Transporteurs ABC/génétique , Paracoccidioides/génétique , Paracoccidioides/métabolisme , Protéines de transport membranaire/effets des médicaments et des substances chimiques , Protéines de transport membranaire/génétique , Protéines de transport membranaire/physiologie , Multirésistance des champignons aux médicaments/physiologie , Transporteurs ABC/effets des médicaments et des substances chimiques , Transporteurs ABC/métabolisme
SÉLECTION CITATIONS
Détails de la recherche